GPT and preeclampsia: Notably, their outcomes can be dramatic5 and there is no single laboratory test or variable that predicts the disease progression and outcomes with certainty.9,10 Stringent laboratory monitoring, defined by the authors as testing at least blood levels of serum Creatinine, Haemoglobin concentration, Alanine transaminase (ALT) and Platelet count (CHAP) weekly in patients already diagnosed to have gestational hypertension, TGH or PE without severe features, may offer the best pregnancy outcomes.